CodeLifeAI founder honored at Forbes China ESG summit

By AI, Created 4:33 PM UTC, May 18, 2026, /AGP/ – Dr. Keith Wai-Yeung Kwong, founder of Hong Kong-based CodeLifeAI, was recognized in the Life Sciences category at the 2025 Forbes China ESG Impact Enterprise Figures Summit in April 2026. The award spotlights his push to use AI, DNA design and protein engineering to speed biotechnology research and expand access to life sciences tools and education.

Why it matters: - Dr. Keith Wai-Yeung Kwong’s recognition puts a spotlight on AI-powered biotechnology as a growing force in life sciences. - CodeLifeAI is positioning itself as a platform that could reduce technical barriers for researchers, educators and students. - The award also ties biotechnology innovation to ESG and sustainable development themes.

What happened: - Dr. Keith Wai-Yeung Kwong, a Hong Kong biomedical scientist and founder of CodeLifeAI, was honored in the Life Sciences category at the 2025 Forbes China ESG Impact Enterprise Figures Summit and Awards Ceremony. - The ceremony took place on the evening of April 28, 2026. - The summit was held in Hong Kong.

The details: - The Forbes China ESG Impact Enterprise Figures selection recognizes enterprise leaders and innovators who combine ESG values with technological development, business innovation and social impact. - The summit brought together leaders across life sciences, artificial intelligence, robotics, low-altitude economy, new energy, carbon neutrality, women leadership, youth leadership and international business. - CodeLifeAI is an AI-powered biotechnology platform focused on DNA design, protein engineering, CRISPR applications, AAV vector design, biological data interpretation and life sciences education. - The platform also supports biomolecular visualization, biological data management, educational content generation and AI-assisted experimental planning. - CodeLifeAI is designed to support DNA sequence analysis, protein structure understanding and functional prediction. - The platform is intended to help users move faster through the design-build-test cycle in biotechnology. - Dr. Kwong said biotechnology is entering a new era in which artificial intelligence will become a central engine for discovery. - Dr. Kwong said CodeLifeAI was created to help scientists and students interact with biological systems more intuitively.

Between the lines: - The recognition reflects a broader bet that biology is becoming more computational and more accessible. - CodeLifeAI’s education focus suggests the company is targeting not only research labs, but also schools and early-stage scientists. - The Hong Kong and Greater Bay Area context points to a regional push to link research, talent, capital and manufacturing. - Dr. Kwong’s comments at the summit frame AI as a tool for faster disease-mechanism discovery, biomolecule design and preclinical research.

What’s next: - CodeLifeAI plans to keep developing AI-driven tools for DNA, protein, CRISPR, AAV and broader life sciences workflows. - The company is also continuing to build learning tools for students, schools and researchers. - Dr. Kwong’s long-term goal is an intelligent biotechnology platform that helps users design, learn, experiment and innovate more efficiently.

The bottom line: - The award gives CodeLifeAI a public boost as it tries to make AI a core part of biotechnology research and education.